Copy number variations as potential diagnostic and prognostic markers for CNS melanocytic neoplasms in neurocutaneous melanosis

This is a preview of subscription content, log in to check access.

Fig. 1

References

  1. 1.

    Bastian BC, Olshen AB, LeBoit PE, Pinkel D (2003) Classifying melanocytic tumors based on DNA copy number changes. Am J Pathol 163:1765–1770

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  2. 2.

    Bastian BC, Xiong J, Frieden IJ, Williams ML, Chou P, Busam K, Pinkel D, LeBoit PE (2002) Genetic changes in neoplasms arising in congenital melanocytic nevi: differences between nodular proliferations and melanomas. Am J Pathol 161:1163–1169

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  3. 3.

    Brat DJ, Perry A, Wesseling P, Bastian BC (2016) Melanocytic tumors. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Ellison DW, Figarella-Branger D, Perry A, Reifenberger G, von Deimling A (eds) WHO classification of tumours of the central nervous system. IARC, Lyon, pp 266–270

    Google Scholar 

  4. 4.

    Grini-Mazouzi M, Thouvenot E, Sabaah M, Rigau V, Charif M (2012) Leptomeningeal melanocytosis: a fatal course of a benign tumor. Rev Neurol 168:461–463

    CAS  Article  PubMed  Google Scholar 

  5. 5.

    Kinsler VA, Thomas AC, Ishida M, Bulstrode NW, Loughlin S, Hing S, Chalker J, McKenzie K, Abu-Amero S, Slater O et al (2013) Multiple congenital melanocytic nevi and neurocutaneous melanosis are caused by postzygotic mutations in codon 61 of NRAS. J Invest Dermatol 133:2229–2236

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  6. 6.

    Kusters-Vandevelde HV, Willemsen AE, Groenen PJ, Kusters B, Lammens M, Wesseling P, Djafarihamedani M, Rijntjes J, Delye H, Willemsen MA et al (2014) Experimental treatment of NRAS-mutated neurocutaneous melanocytosis with MEK162, a MEK-inhibitor. Acta Neuropathol Commun 2:41

    Article  PubMed  PubMed Central  Google Scholar 

  7. 7.

    Waelchli R, Aylett SE, Atherton D, Thompson DJ, Chong WK, Kinsler VA (2015) Classification of neurological abnormalities in children with congenital melanocytic naevus syndrome identifies magnetic resonance imaging as the best predictor of clinical outcome. Br J Dermatol 173:739–750

    CAS  Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

This work was supported by a research grant from the Koppie-Au foundation, Breda, The Netherlands.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Heidi V. N. Küsters-Vandevelde.

Ethics declarations

Conflict of interest

The authors state no conflict of interest.

Additional information

A. C. H. van Engen-van Grunsven and K. Rabold contributed equally to this work.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 34 kb)

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

van Engen-van Grunsven, A.C.H., Rabold, K., Küsters-Vandevelde, H.V.N. et al. Copy number variations as potential diagnostic and prognostic markers for CNS melanocytic neoplasms in neurocutaneous melanosis. Acta Neuropathol 133, 333–335 (2017). https://doi.org/10.1007/s00401-016-1654-x

Download citation

Keywords

  • Melanoma
  • Copy Number Variation
  • Cutaneous Melanoma
  • Copy Number Loss
  • Primary Cutaneous Melanoma